Federal Register / Vol. 76, No. 61 / Wednesday, March 30, 2011 / Notices 17621 

received. Decision: Approved. Reasons: 

This instrument is unique because it has 

a motorized stage, which can be 

programmed to automatically move to 

predetermined positions, and the 

joystick electronic. We know of no 

instruments of equivalent scientific 

value to the foreign instruments 

described below, for such purposes as 

this is intended to be used, that was 

being manufactured in the United States 

at the time of its order. 

Docket Number: 10–077. Applicant: 

University of Chicago LLC, Lemont, IL 

60439. Instrument: Batch Furnace. 

Manufacturer: NGK Insulators Ltd., 

Japan. Intended Use: See notice at 76 FR 

11200, March 1, 2011. Comments: None 

received. Decision: Approved. Reasons: 

This batch furnace includes high 

distribution of the sample (multiple 

trays), which allows for faster drying 

and greater uniformity than a 

conventional furnace. This batch 

furnace also has an oxygen control 

system that has a 10kg batch size. We 

know of no instruments of equivalent 

scientific value to the foreign 

instruments described below, for such 

purposes as this is intended to be used, 

that was being manufactured in the 

United States at the time of its order. 

Docket Number: 11–001. Applicant: 

Michigan State University, East Lansing, 

MI 48824–1226. Instrument: Diode 

Pumped High Speed Nd: YAG laser 

system. Manufacturer: Edgewave GmbH, 

Germany. Intended Use: See notice at 76 

FR 11200, March 1, 2011. Comments: 

None received. Decision: Approved. 

Reasons: The main feature of the laser, 

which is particularly suited for the 

necessary application, is the beam 

profile (M2<2) and energy stability over 

lengthy operation times, which is 

critical when quantifying combustion 

species using PLIF over different 

operation modes. This is the only laser 

that can do sub 10 ns pulses with all the 

different specifications. We know of no 

instruments of equivalent scientific 

value to the foreign instruments 

described below, for such purposes as 

this is intended to be used, that was 

being manufactured in the United States 

at the time of its order. 

Dated: March 23, 2011. 

Gregory W. Campbell, 

Director, Subsidies Enforcement Office, 

Import Administration. 

[FR Doc. 2011–7493 Filed 3–29–11; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

International Trade Administration 

Biotech Life Science Trade Mission to 

China 

AGENCY: International Trade 

Administration, Department of 

Commerce. 

ACTION: Notice. 

Mission Description 

The United States Department of 

Commerce, International Trade 

Administration, U.S. and Foreign 

Commercial Service (CS) is organizing a 

Biotechnology Life Sciences trade 

mission to China on October 17–20, 

2011. Led by a senior Department of 

Commerce official, the mission to China 

is intended to include representatives 

from a variety of U.S. biotechnology and 

life science firms and trade 

organizations. The mission will 

introduce mission participants to endusers, prospective partners, and 

investors whose needs and capabilities 

are targeted to the respective U.S. 

participant’s strengths and needs. 

Participating in an official U.S. industry 

delegation, rather than traveling to 

China independently, will enhance the 

participants’ ability to secure meetings 

in China. The mission will include site 

visits to biotech industrial parks, 

government meetings, and receptions in 

Beijing and Hong Kong. Trade mission 

participants will have the opportunity 

to interact with Commercial Service 

(CS) specialists and State Department 

officers covering intellectual property 

rights issues and biotechnology to 

discuss industry developments, 

opportunities, and sales strategies. 

Commercial Setting 

U.S. biotech and life science firms 

often consider China the most important 

future market in terms of sales and 

clinical trial opportunities, and 

potential investment. China’s enormous 

consumer base and impressive 

economic growth further reinforce the 

importance of the market for U.S. firms. 

However, China’s legal and regulatory 

landscape often complicates market 

entrance for many U.S. firms. Since 

these trade policy issues are frequent 

topics of high-level bilateral discussions 

between the U.S. Government and the 

Chinese Government, a Trade Mission 

led by the U.S. Department of 

Commerce offers an attractive entre ́e for 

U.S. firms and associations in the 

Chinese market. With some 200 

pharmaceutical companies operating in 

Hong Kong (with many involved in the 

fast-growing specialty of Chinese 

Traditional Medicine), which possesses 

excellent research facilities and 

business infrastructure, regulatory 

linkages into the mainland, and a strong 

venture capital community, Hong Kong 

offers an ideal complement to a policycentered mission program in Beijing. 

Hong Kong is also a leading center for 

bio-medical clinical trials in Asia. 

The Biotech Life Science Sector 

Despite the global financial crisis, 

China’s GDP growth is widely expected 

to grow by approximately eight percent 

in 2011. While U.S. venture capital 

investment in biotech and life science 

companies has slowed, Chinese 

pharmaceutical and biotech industries 

are demonstrating a healthy appetite for 

funding novel, early-stage technologies. 

Major U.S. biotech firms have 

established licensing and partnering 

offices in China specifically to seek 

these opportunities. 

Over 2,000 novel molecules have been 

patented in China, 96 are in clinical 

trials, and 27 new drugs have launched 

in the last five years, 20 of which are 

novel biologics. There are novel 

molecules at all stages of development 

in China, and Chinese companies and 

institutes are anxious to partner with 

Western companies for development 

and distribution of these valuable assets. 

There are also over 300 clinical 

research organizations in China offering 

high quality services supporting drug 

discovery and development projects of 

major pharmaceutical and biotech 

companies worldwide. Many of these 

are willing to work on a risk sharing or 

collaborative basis with their sponsors. 

Mission Goals 

The short term goals of the trade 

mission to China are to (1) introduce 

U.S. participants to potential customers 

and strategic partners, including 

investors, (2) introduce U.S. participants 

to industry and government officials in 

China to learn about various 

opportunities, and (3) to educate the 

participants about trade policy and 

regulatory matters involved in doing 

business in China. 

Mission Scenario 

In Beijing, the U.S. mission members 

will be briefed by the U.S. Embassy’s 

Counselor for Commercial Affairs, the 

Commercial Specialist for the 

biotechnology sector, and other key U.S. 

Government officials. Senior Embassy 

officials will host a networking event for 

the group with Chinese biotech and life 

science industry organizations and 

multipliers. In Hong Kong, U.S. 

participants will benefit from 

customized one-on-one matchmaking 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

17622 Federal Register / Vol. 76, No. 61 / Wednesday, March 30, 2011 / Notices 

1An SME is defined as a firm with 500 or fewer 

employees or that otherwise qualifies as a small 

business under SBA regulations (see http:// 

www.sba.gov/services/contractingopportunities/ 

sizestandardstopics/index.html). Parent companies, 

affiliates, and subsidiaries will be considered when 

determining business size. The dual pricing reflects 

the Commercial Service’s user fee schedule that 

became effective May 1, 2008 (see http:// 

www.export.gov/newsletter/march2008/ 

initiatives.html for additional information). 

with potential partners, a market 

briefing by the Commercial Specialist 

for the biotech life science sector at the 

U.S. Consulate, and networking 

activities. Site visits to Hong Kong’s 

Science & Technology Park and leading 

research universities may be offered. 

One week prior to the Trade Mission, 

it should also be noted that from 

October 12–13, there will be a BIO 

China (http://www.bio.org/biochina) 

trade event in Shanghai that will focus 

on the biotech sector. Though BIO 

China is not officially linked to the 

Commerce Department’s Biotech Life 

Science Trade Mission to China, U.S. 

trade mission participants may opt to 

precede the October 17–20, 2011 Trade 

Mission by participating in this event. 

Participation in the mission will 

include the following: 

• Pre-travel briefings/webinar on 

subjects ranging from business practices 

in China to intellectual property rights; 

• Pre-scheduled meetings with 

potential partners, distributors, end 

users, Clinical Research Organizations, 

or investors in Hong Kong; 

• Transportation to and from airports 

in Beijing and Hong Kong; 

• Meetings with Chinese Government 

officials; 

• Participation in industry receptions 

in Beijing and Hong Kong; 

• Meetings with CS China’s biotech 

and life science industry specialists in 

Beijing and Hong Kong. 

Proposed Timetable 

Mission participants will be 

encouraged to arrive October 15 or 16, 

2011 and the mission program will 

proceed from October 17 through 

October 20, 2011. 

October 17 Beijing. 

Market briefings by U.S. Embassy Beijing officials. 

Meetings with Chinese Ministry 

of Health and State Food and 

Drug Administration officials. 

Networking reception. 

October 18 Beijing. 

Tour of Bio Parks and Research 

Facilities. 

Travel to Hong Kong. 

Business meetings. 

October 19 Hong Kong. 

One-on-one business matchmaking appointments 

Briefings from Hong Kong government, industry association, 

and American Chamber representatives. 

Tour of Science & Technology 

Parks. 

Networking reception 

October 20 Hong Kong. 

One-on-one business matchmaking appointments. 

Visits to Research Facilities 

(tbd). 

Participation Requirements 

All parties interested in participating 

in the Biotech Life Science Trade 

Mission to China must complete and 

submit an application for consideration 

by the Department of Commerce. All 

applicants will be evaluated on their 

ability to meet certain conditions and 

best satisfy the selection criteria as 

outlined below. A minimum of 15 and 

a maximum of 20 participants will be 

selected for the mission from the 

applicant pool. U.S. companies and 

associations already involved with and/ 

or doing business in China as well as 

U.S. companies and associations 

seeking exposure to the market for the 

first time are encouraged to apply. 

Fees and Expenses 

After a participant has been selected 

for the mission, a payment to the 

Department of Commerce in the form of 

a participation fee is required. The 

participation fee will be $3,270 for large 

firms and $2,327 for a small or mediumsized enterprise (SME) 1 or small trade 

organization, which will cover one 

representative. The fee for each 

additional firm representative (large 

firm or SME) is $500. Expenses for 

travel, lodging, most meals, and 

incidentals will be the responsibility of 

each mission participant. 

Conditions for Participation 

An applicant must submit a 

completed and signed mission 

application and supplemental 

application materials, including 

adequate information on the company’s 

products and/or services, primary 

market objectives, and goals for 

participation. If the U.S. Department of 

Commerce receives an incomplete 

application, the Department may reject 

the application, request additional 

information, or take the lack of 

information into account when 

evaluating the applications. 

• Each applicant must also certify 

that the products and services it seeks 

to export through the mission are either 

produced in the United States, or, if not, 

marketed under the name of a U.S. firm 

and have at least fifty-one percent U.S. 

content. 

Selection Criteria for Participation 

Selection will be based on the 

following criteria: 

• Suitability of a company’s products 

or services to the mission’s goals; 

• Applicant’s potential for business 

in China, including likelihood of 

exports resulting from the trade mission; 

• Consistency of the applicant’s goals 

and objectives with the stated scope of 

the trade mission. 

Referrals from political organizations 

and any documents containing 

references to partisan political activities 

(including political contributions) will 

be removed from an applicant’s 

submission and not considered during 

the selection process. 

Timeframe for Recruitment and 

Applications 

Mission recruitment will be 

conducted in an open and public 

manner, including publication in the 

Federal Register, posting on the 

Commerce Department trade mission 

calendar (http://export.gov/ 

trademissions/) and other Internet Web 

sites, press releases to general and trade 

media, direct mail, notices by industry 

trade associations and other multiplier 

groups, and publicity at industry 

meetings, symposia, conferences, and 

trade shows. Recruitment for the 

mission will begin immediately and 

conclude no later than 08/15/2011. The 

U.S. Department of Commerce will 

review all applications immediately 

after the deadline. We will inform 

applicants of selection decisions as soon 

as possible after 08/15/2011. 

Applications received after that date 

will be considered only if space and 

scheduling constraints permit. 

Contacts 

U.S. Commercial Service Domestic 

Contact: Douglas Wallace, Commercial 

Officer, 415–705–1765, 

Douglas.Wallace@trade.gov. 

Elnora Moye, 

U.S. Department of Commerce, International 

Trade Administration. 

[FR Doc. 2011–7471 Filed 3–29–11; 8:45 am] 

BILLING CODE 3510–FP–P 

DEPARTMENT OF COMMERCE 

International Trade Administration 

U.S. Education Mission to India 

AGENCY: International Trade 

Administration, Department of 

Commerce. 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES